SEC Form 4 research

Vistagen Therapeutics, Inc. insider transactions

IssuerVistagen Therapeutics, Inc.
TickersEXCA, VSTA, VTGN, VSTA.OB
Reporting owners38
Officers and directors7
Last public filing2026-08-01

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-07-312026-07-29Williamson Douglas JA40,826$0Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page